Insider trading

Period: 120 months Stock: KYMR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

204 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

204 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

204 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

204 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
204 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
204 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

204 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Mar 2024
Sold on a plan 2×
$1.81M 42,302 at 42.85
0.9%
Planned (10b5-1)
11 Mar 2024
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold on a plan 2×
$380.56K 8,882 at 42.85
1.0%
Planned (10b5-1)
4 Mar 2024
Jacobs Bruce N. Chief Financial Officer
Sold at will 3×
$164.66K 3,934 at 41.86
2.7%
Not planned
4 Mar 2024
Gollob Jared Chief Medical Officer
Sold at will 3×
$139.97K 3,344 at 41.86
3.4%
Not planned
27 Feb 2024
Gollob Jared Chief Medical Officer
Sold on a plan
$18.00K 400 at 45.00
0.5%
Planned (10b5-1)
21 Feb 2024
Sold on a plan
$171.23K 4,385 at 39.05
100%
Sold half or more
20 Feb 2024
Sold on a plan
$24.03K 615 at 39.07
100%
Sold half or more
9 Feb 2024
Gollob Jared Chief Medical Officer
Sold on a plan 2×
$1.64M 46,137 at 35.50
38.2%
Planned (10b5-1)
23 Jan 2024
Sold on a plan
$300.47K 10,000 at 30.05
100%
Sold half or more
4 Jan 2024
Chiniara Ellen Chief Legal Officer
Sold at will
$74.42K 3,295 at 22.58
8.8%
Not planned
3 Nov 2023
Bought 3×
$2.78M 197,699 at 14.07
8.0%
2 Nov 2023
Bought 3×
$2.52M 216,406 at 11.64
9.3%
2 Mar 2023
Jacobs Bruce N. Chief Financial Officer
Sold, plan not stated 2×
$42.47K 1,370 at 31.00
1.3%
2 Mar 2023
Gollob Jared Chief Medical Officer
Sold, plan not stated 2×
$40.23K 1,298 at 31.00
1.7%
2 Mar 2023
Caughey Elaine Chief Business Officer
Sold, plan not stated 2×
$22.13K 714 at 31.00
3.6%
12 Jan 2023
Booth Bruce Director · indirect
Sold, plan not stated 2×
$2.99M 98,720 at 30.29
10.0%
12 Jan 2023
Sold, plan not stated
$2.34M 77,128 at 30.29
1.5%
12 Jan 2023
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$654.02K 21,592 at 30.29
2.4%
12 Jan 2023
Bought 2×
$590.39K 18,897 at 31.24
0.8%
11 Jan 2023
Booth Bruce Director · indirect
Sold, plan not stated 2×
$831.51K 27,754 at 29.96
3.0%
11 Jan 2023
Bought 2×
$660.80K 22,110 at 29.89
0.9%
11 Jan 2023
Sold, plan not stated
$649.62K 21,683 at 29.96
0.4%
11 Jan 2023
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$181.89K 6,071 at 29.96
0.7%
15 Dec 2022
Booth Bruce Director · indirect
Sold, plan not stated 2×
$98.34K 3,278 at 30.00
0.4%
15 Dec 2022
Sold, plan not stated
$76.83K 2,561 at 30.00
0.1%
15 Dec 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$21.51K 717 at 30.00
0.1%
14 Dec 2022
Booth Bruce Director · indirect
Sold, plan not stated 10×
$11.89M 378,966 at 31.37
29.2%
14 Dec 2022
Sold, plan not stated 5×
$9.29M 296,077 at 31.37
5.5%
14 Dec 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated 5×
$2.60M 82,889 at 31.37
8.3%
3 Nov 2022
Booth Bruce Director · indirect
Sold, plan not stated 2×
$2.89M 96,397 at 30.00
8.8%
3 Nov 2022
Sold, plan not stated
$2.26M 75,312 at 30.00
1.4%
3 Nov 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$632.55K 21,085 at 30.00
2.1%
2 Nov 2022
Booth Bruce Director · indirect
Sold, plan not stated 2×
$3.71M 123,619 at 30.02
10.8%
2 Nov 2022
Sold, plan not stated
$2.90M 96,581 at 30.02
1.7%
2 Nov 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$811.68K 27,038 at 30.02
2.6%
1 Nov 2022
Booth Bruce Director · indirect
Sold, plan not stated 4×
$2.36M 77,030 at 30.60
6.8%
1 Nov 2022
Sold, plan not stated 2×
$1.84M 60,182 at 30.60
1.1%
1 Nov 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated 2×
$515.58K 16,848 at 30.60
1.6%
31 Oct 2022
Booth Bruce Director · indirect
Sold, plan not stated 2×
$3.65M 120,622 at 30.23
10.2%
31 Oct 2022
Sold, plan not stated
$2.85M 94,239 at 30.23
1.7%
31 Oct 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$797.56K 26,383 at 30.23
2.4%
28 Oct 2022
Booth Bruce Director · indirect
Sold, plan not stated 2×
$2.73M 91,050 at 30.00
7.7%
28 Oct 2022
Sold, plan not stated
$2.13M 71,135 at 30.00
1.2%
28 Oct 2022
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$597.45K 19,915 at 30.00
1.8%
22 Aug 2022
Bought 3×
$14.18M 545,525 at 26.00
28.2%
+28% of stake
27 May 2022
Bought 3×
$966.34K 65,369 at 14.78
3.1%
26 May 2022
Bought 3×
$3.18M 224,057 at 14.21
11.6%
20 May 2022
Bought 3×
$141.39K 10,100 at 14.00
0.5%
6 May 2022
Bought 3×
$1.93M 100,000 at 19.26
5.2%
5 May 2022
Bought 3×
$2.94M 150,000 at 19.60
8.2%
Showing 101–150 of 204. ← Newer Page 3 of 5 Older →